ANALYSIS OF METABOLISM IN MULTIPLE SCLEROSIS PATIENTS

被引：0
|
作者：
NEU, I [1 ]
机构：
[1] UNIV MUNICH,KLINIKUM GROSSHADERN,MED KLIN & POLIKLIN,D-8000 MUNICH 70,FED REP GER
来源：
FORTSCHRITTE DER MEDIZIN | 1979年 / 97卷 / 27期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1211 / 1211
页数：1
相关论文
共 50 条
  • [41] Safety of ocrelizumab in multiple sclerosis: Updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, S.
    Kappos, L.
    Montalban, X.
    Craveiro, L.
    Hughes, R.
    McNamara, J.
    Pradhan, A.
    Wormser, D.
    Koendgen, H.
    Wolinsky, J. S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [42] Safety of ocrelizumab in multiple sclerosis: Updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, Stephen
    Kappos, Ludwig
    Montalban, Xavier
    Chognot, Cathy
    Jessop, Nikki
    Kadner, Karen
    Pradhan, Ashish
    Incera, Elodie
    Wolinsky, Jerry
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 352 - 353
  • [43] Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, S.
    Kappos, L.
    Montalban, X.
    Chognot, C.
    Craveiro, L.
    Pradhan, A.
    Prajapati, K.
    Wolinsky, J.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 306 - 306
  • [44] Safety of ocrelizumab in multiple sclerosis: Updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Chognot, C.
    Jessop, N.
    Kadner, K.
    Pradhan, A.
    Prajapati, K.
    Wolinsky, J. S.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 354 - 355
  • [45] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Prajapati, K.
    Koendgen, H.
    Craveiro, L.
    Hughes, R.
    Pradhan, A.
    Wolinsky, J.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 68 - 69
  • [46] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients with Relapsing and Primary Progressive Multiple Sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Koendgen, H.
    Li, C.
    Marcillat, C.
    Pradhan, A.
    Wormser, D.
    Wolinsky, J. S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 334 - 334
  • [47] Disrupted Cerebral Metabolism in Multiple Sclerosis
    Brier, Matthew R.
    Judge, Bradley
    Ying, Chunwei
    An, Hongyu
    Cross, Anne
    Benzinger, Tammie
    Goyal, Manu
    ANNALS OF NEUROLOGY, 2023, 94 : S66 - S66
  • [48] STUDIES ON PHOSPHATE METABOLISM IN MULTIPLE SCLEROSIS
    HUSZAK, I
    SZECHENYI, F
    ACTA CHEMICA SCANDINAVICA, 1963, 17 : 319 - &
  • [49] Dysregulation of methionine metabolism in multiple sclerosis
    Singhal, N. K.
    Freeman, E.
    Arning, E.
    Wasek, B.
    Clements, R.
    Sheppard, C.
    Blake, P.
    Bottiglieri, T.
    McDonough, J.
    NEUROCHEMISTRY INTERNATIONAL, 2018, 112 : 1 - 4
  • [50] Targeting metabolism to treat multiple sclerosis
    Pavan Bhargava
    Neural Regeneration Research, 2021, 16 (03) : 502 - 503
12345